| Name | Title | Contact Details |
|---|
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Sellers Dorsey is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Amerimed Medical Solutions is a healthcare company that provides emergency medical services and mobile integrated healthcare in several states in the US.
Heartbeat Perfusion Solutions is a nationwide supplier of perfusion and ECMO services that offers a consultative approach to deliver innovative Cardiovascular Perfusion and ECMO services that meet the needs of hospitals and healthcare facilities.
TeamHealth Medical Call Center is a Knoxville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.